Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in small-batch clinical production of biologics, announced the first closing of its Series A financing round.
The Oklahoma City Innovation District’s 2022 Annual Breakfast will be held on November 2, beginning at 8 a.m. at the OMNI Hotel.
The Oklahoma City Innovation District will soon welcome a “once-in-a-generation” biomanufacturing workforce training center (BWTC) program to benefit all Oklahomans. One of the only programs of its kind within the United States, the BWTC program presents inclusive, non-degreed careers within the city’s emerging bioscience industry.
Greater Oklahoma City Chamber Executive Vice President Jeff Seymour was in Washington, D.C., this morning attending an invitation-only biotechnology summit at the White House. The event launched a new initiative designed to ensure America’s place in the world of biotechnology and biomanufacturing.
President Biden announced the Oklahoma Biotech Innovation Cluster as one of 21 winners of the $1 billion Build Back Better Regional Challenge, the most impactful regional economic development competition in decades.
The Chamber’s Economic Development staff is on a constant mission to grow existing industries, recruit new companies and develop an active entrepreneurial environment, with the goal of creating quality jobs and a diverse economy for the region; in other words, bring new investment to the city.
The San Diego Convention Center was booming with wall-to-wall activity last month as thousands of bioscience professionals converged for the 2022 Biotechnology Innovation Organization International Convention (BIO). Among them was a large contingent from Oklahoma who joined forces as part of the Oklahoma Biosciences Association (OKBio) exhibitor booth.
Chamber members, Oklahoma Health Sciences Center (OUHSC) and Oklahoma Medical Research Foundation (OMRF), were granted $5.5 million from Presbyterian Health Foundation (PHF) for medical research.
